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 Sepsis is a highly dynamic condition caused by a dysregulated host response to a pathogen 
in the bloodstream. Fast and accurate diagnosis of the causative pathogen is critical to provide 
effective treatment and minimize the risk of death. The current diagnostic workflow for a blood 
stream infection begins with a blood draw from the patient into a culture bottle, which is then 
incubated in an automated blood culture instrument to detect growth of the pathogen. Common 
automated blood culture systems, such as Becton Dickinson’s BACTEC franchise, utilize glass 
culture bottles containing a fluorescence-based sensor to aid detection of bacterial growth. After 
detection of growth by the instrument, the bacteria are isolated via an overnight subculture to 
provide a sample for downstream testing. Once isolated, bacteria can then be identified and tested 
for antimicrobial susceptibility. 
In this thesis, we characterize and optimize two aspects of the diagnostic workflow in order 
to improve sepsis diagnosis and patient management. The first chapter details characterization of 
and improvements to a filtration system designed to decrease the time to diagnosis by isolating 
bacteria from a positive blood culture in 15 minutes. To improve the quality of the isolated sample 
for accurate identification and antimicrobial susceptibility testing, we assessed the current 
performance of the system. We then improved recovery and downstream results by adjusting the 
filtration workflow and increasing the area through which the positive blood culture is filtered. 
The second chapter targets conversion of the current glass blood culture bottle to a safer, lighter 
polycarbonate bottle. We characterized formulations for the polycarbonate bottle’s fluorescence-
based sensor in order to ensure proper adhesion to the bottle and define the signal ranges. With 
this, we selected a formulation for scale up to biological testing, which will assess the sensitivity 
of signal detection and allow the new polycarbonate bottle to be brought to market. Both 
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conversion of the blood culture bottle to a safer material and reduction of bacterial isolation time 
will improve the diagnostic workflow for a bloodstream infection, ultimately allowing for easier 
diagnosis and treatment of sepsis.  
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Chapter 1: Optimization of Positive Blood Culture 
Processing for Rapid Identification and Antimicrobial 






Sepsis, clinically defined as a dysregulated host response to a pathogen in the bloodstream, 
accounts for 25% of hospital deaths and $20 billion in health care expenses annually1, 2. Diagnosis 
of the causative infection requires a blood culture to detect growth of microorganisms, followed 
by evaluation of the positive blood culture (PBC) for identification (ID) and antimicrobial 
susceptibility testing (AST). Rapid and accurate ID/AST results are critical to avoid broad or 
ineffective treatment and minimize toxicity to beneficial bacteria. Current ID/AST workflows 
require an 18-hour subculture from the PBC to provide an isolated sample for downstream testing. 
Previous work confirmed the feasibility of using tangential flow filtration to isolate bacteria from 
a PBC in 15 minutes, reducing the time required for isolation; however, this concept requires 
further development to reduce processing time, maximize output, and minimize loss of bacteria.  
We used the filtration system to process 30 strains of bacteria grown in three different types 
of BACTEC (Becton Dickinson (BD)) media in order to set a baseline of performance for filtration 
(PBC processing), matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI ToF MS) ID, and Phoenix™ (BD) AST. Baseline performance results showed that Gram 
negative bacteria filter well to yield accurate ID/AST results across all three media types; however, 
Gram positive bacteria proved difficult to filter and did not consistently yield accurate ID/AST 
results. We attributed these difficulties to lack of bacteria and excess blood background in the 
output. In order to provide a more isolated and concentrated sample, we targeted the lysis and wash 
steps of PBC processing. Furthermore, we hypothesized that lack of bacteria stems from cake layer 
formation atop the filter membrane, becoming more apparent for smaller filter pore sizes. For 
Gram positive bacteria, we also attributed lack of bacteria to their clumping nature and subsequent 
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inability to fit through the pores. Thus, we increased the pore size and yielded higher percent 
recovery and more accurate ID/AST results for the problematic Gram positive bacteria.  
Further optimization of filter geometry, operating vacuum pressure, and sample flowrate 
will minimize cake formation and improve isolated bacterial recovery. Moreover, definition of 
limits of detection for MALDI ID and Phoenix AST will set standards for filter performance, 





 Defined as an abnormal host immune response to infection with a pathogen in the 
bloodstream, sepsis occurs in 30 million people worldwide, with an estimated 6 million deaths 
annually2, 3. In the US alone, it accounts for $20B (5.2%) of annual healthcare expenditures2. The 
incidence of sepsis appears to be increasing, most likely due: (1) an aging population that becomes 
more susceptible as they live longer; (2) a growing number of antimicrobial-resistant (AMR) 
strains due to overuse of broad spectrum drugs; and (3) an increase in the number of people living 
with weakened immune systems caused by HIV, transplant drugs, cancer treatments, etc. 
With no diagnostic tool designed specifically for sepsis, physicians generally begin treating 
patients with broad-spectrum drugs immediately upon onset of physical symptoms (e.g. fever, high 
heart/respiratory rates)4. In order to narrow the spectrum and provide more effective treatment, the 
causative pathogen must be identified and tested for antimicrobial susceptibility. Currently, this 
takes up to 50 hours and involves a blood draw and culture to detect growing microorganisms, 
classification of the Gram type to give a preliminary phenotypic ID, isolation of the 
microorganisms from the culture, and finally, identification (ID) and antimicrobial susceptibility 
testing (AST). Isolation from the blood culture necessitates a subculture requiring 18-24 hours of 
growth, significantly delaying ID/AST results. Sepsis is a highly dynamic illness, and thus time is 
critical. Early, specific treatment shows reduction in mortality rates5. Moreover, rapid ID/AST 
results avoid ineffective treatment, limit selection of resistant strains from broad-spectrum drugs, 
and minimize elimination of beneficial bacteria. 
Becton Dickinson (BD), a worldwide leader in microbiology diagnostic solutions, holds 
capabilities in pathogen detection, ID, and AST. Recent work proved the feasibility of a tangential 
flow filtration device that isolates bacteria from the blood culture in 15 minutes, eliminating the 
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need for a subculture and providing a concentrated sample for rapid initiation of ID/AST. This 
technology evolved from a separate application however, and thus the ideal processing parameters 
and limitations of the system remained relatively unknown for application to rapid ID/AST.  
The goal of this project involved further characterization and optimization of this 
technology in order to reduce processing time, maximize recovery from the blood culture, and 
ensure a viable input for ID/AST. We tested a variety of bacterial strains and media types in order 
to set a baseline for filtration performance and suitability of the output for ID/AST. This allowed 
us to identify weaknesses within the filtration technology and causes for poor ID/AST results. We 
characterized and optimized steps within the processing workflow, as well as adjusted filtration 
parameters based upon the results of the baseline study. This allowed us to determine the key 
factors of yielding quicker, more accurate ID/AST results from outputs of the technology. 
BACKGROUND 
 While sepsis exists as one of the most common causes of death in hospitals, its diagnosis 
remains challenging due to the likelihood of a preexisting condition within the patient. Commonly 
characterized by three stages, stage one sepsis presents with a high fever and increased heart rate. 
As infection spreads and sepsis progresses to the second stage, symptoms include shortness of 
breath and organ dysfunction. The third and most severe stage is known as septic shock, and is 
characterized by extremely low blood pressure that leads to multiple organ failure and often death. 
Progression through the stages is often very quick—on the order of days or even hours—and thus 
time is critical.  Since sepsis is most often caused by an infection of bacteria in the bloodstream, 
speeding up the time to a confirmatory diagnosis of the bacteria and recommendations for effective 




Current Workflow for Diagnosis of a Blood Stream Infection 
 In order to develop a more effective, narrow treatment regime for sepsis patients, 
physicians must identify the pathogen causing the blood stream infection. The workflow for this 
diagnosis begins with a roughly 10mL blood draw into a culture bottle containing growth media 
(Figure 1).  
 
Figure 1: Current Workflow for Diagnosis of a Bloodstream Infection Based Upon use of BD Diagnostic 
Equipment. The current workflow for diagnosis of a bloodstream infection involves collection and transport of a 
blood culture (0-4 hours); incubation and detection of growth in a BACTEC instrument (20 hours); Gram staining for 
preliminary phenotypic identification (<1 hour); growth of a subculture to isolate pathogens (18-24 hours); MALDI 
ID (<1 hour); and Phoenix AST (8 hours). 
Sepsis patients generally have only 10-100 CFU per 10mL blood draw, and thus the bacteria must 
be grown in order to confirm infection with a pathogen and yield enough material for downstream 
testing. For the BACTEC system, culture bottles can contain various types of growth media, such 
as: lytic media, which contains saponin for lysing blood cells and releasing intracellular pathogens; 
PLUS media, which contains ion-exchange resin beads that sequester any antibiotics already 
present in the patient that inhibit bacterial growth; and standard aerobic media, which provides 
growth for aerobes. After collection and transport of the samples to an automated blood culture 
instrument (e.g. BACTEC), the instrument incubates and continuously monitors the samples in 
order to detect growth. The median time to detection (TTD) for bacteria is 20 hours. 
Once growth is detected (generally at about 108 CFU/mL), the culture, now known as a 
positive blood culture (PBC), is removed and a Gram stain is performed. This involves chemical 
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staining of an aliquot of the PBC and gives a preliminary identification of the bacteria based on 
phenotype. Additionally, it allows for identification of a polymicrobial infection. The Gram stain 
classifies bacteria as Gram negative or Gram positive. Gram positive bacteria tend to clump 
together and appear larger than Gram negative bacteria, which appear as rods. Following the Gram 
stain, the bacteria must be isolated from the PBC by plating an aliquot onto a growth plate (i.e. 
purity plate). This isolation step is key to produce a viable input for ID/AST methods; however, 
the length required for growth necessitates the development of more rapid isolation methods. From 
the isolate, a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI 
ToF MS, or MALDI) ID can be made within a few minutes, followed by AST. Although the 
detailed mechanisms of MALDI ID and AST are beyond the scope of this work, it is important to 
understand the basic underlying principles and analyses of results in order to understand how to 
optimize the output of PBC processing for downstream testing. 
Antimicrobial Susceptibility Testing 
 Antimicrobial susceptibility testing (AST) is critical in order to provide accurate, specific 
recommendations for prescribing effective treatment. It allows physicians to narrow treatment 
from broad spectrum antimicrobials to specific concentrations of drugs necessary to kill the 
infective bacteria. Common AST platforms utilize a broth dilution technique, which exposes the 
bacteria to decreasing concentrations of antimicrobial agents in liquid media. Phoenix panels are 
plastic microdilution trays that contain several rows of various dried antimicrobial agents. Each 
row contains 5 twofold serial dilutions (doubling dilutions) of the same antimicrobial agent. Upon 
inoculation of the panel with a redox indicator-bacteria solution and incubation within the 
instrument, Phoenix continuously measures changes in both the redox indicator and turbidity of 
the solution in order to detect growth of the bacteria.  
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The minimal inhibitory concentration (MIC), defined by the lowest doubling dilution in 
which no visible growth occurs, quantifies growth of bacteria in an AST panel. Interpretation of 
AST results include two forms. The first defines isolate MICs as being in essential agreement 
with the regulatory-defined reference MIC of the specific pathogen. Isolates that produce an 
essential agreement fall within ±1 doubling dilution of the reference. The second form calls 
bacteria susceptible (S), intermediate (I), or resistant (R) to the antimicrobial based upon its MIC. 
The bacteria get further defined as being in categorical agreement if it yields the same category 
(S, I, or R). For the scope of this project, we focused only on interpretation of results using essential 
agreements. For part of the validation of medical devices for AST, the FDA requires ≥90% of test 
samples to be in essential agreement6. 
Identification of Pathogens using MALDI-ToF MS 
 Identification of pathogens is key to accurately interpreting AST results and providing 
precise treatment. MALDI is rapidly expanding as a fast, labor-inexpensive method for microbial 
identification. MALDI entails ionization of the test isolate peptides by short laser pulses, which 
create charged molecules that travel up a flight tube within the instrument7, 8. The instrument 
measures the time of flight and creates a peptide mass fingerprint (PMP) that is compared to a 
database for an ID. Analytes are given an identification based upon the yielded spectra and the 
match score. Based upon Bruker Daltonic’s recommendations, a score from 0 to 1.69 yields no 
reliable identification, a score from 1.70 to 1.99 yields a genus-level match, and a score of 2.00 or 
greater yields a species-level match9.  
 Sample preparation for MALDI is relatively simple, but crucial in order to generate 
accurate results. After applying the sample to the target plate, pre-treatment with a strong organic 
acid (e.g. ethanol, formic acid) is critical in order to extract intracellular proteins and remove 
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contaminants. Contaminants may interfere with even sample crystallization within the matrix, 
resulting in low resolution and low identification accuracy. Furthermore, an excess of salts in the 
sample may create a spectrum that dwarfs the desired spectra. Alternatively, protein extraction 
from the sample can be performed prior to application to the plate. This generally provides a 
cleaner sample and allows for more thorough extraction, but is more time consuming as it requires 
various centrifugation and elution steps. Pretreatment and extraction precede application of the 
matrix, which includes energy-absorbent organic compounds7, 10. Once dry, the matrix co-
crystallizes the sample and serves to adsorb and transfer energy from the laser pulses to the sample. 
Positive Blood Culture Processing Approach: Separation via Tangential Flow 
Filtration 
 The main components of a positive blood culture include red and white blood cells in 
addition to bacteria. As seen in Figure 2, both red and white blood cells are more than triple the 
size of a Gram negative bacterial rod. 
 
Figure 2: Main Components of a PBC. Shown to scale from left to right: white blood cell, red blood cell, and 
Gram negative rod. 
Using a polycarbonate track-etched membranes (TEM) with a pore diameter close to that of 
bacteria, tangential flow filtration (TFF) can be applied in order to exclude the blood background 





Figure 3: Tangential Flow Filtration of a Positive Blood Culture. A positive blood culture flows across a track-
etched membrane via a peristaltic pump. A vacuum pump creates a pressure gradient that draws the desired pathogen 
through the TEM pores while excluding the blood background. 
In the PBC processing technology, the sample flows tangentially across the TEM via a peristaltic 
pump, preventing pore clogging. Meanwhile, a vacuum pump creates a pressure gradient to draw 
the bacteria into a collection tube. The retentate, i.e. blood background and any remaining bacteria, 
gets recycled through the apparatus until the entire sample runs through the filter. 
Previous Work with TEM-TFF Technology 
Previously, BD applied this technology to rapid separation of plasma from whole blood. With the 
need to eliminate an 18-hour subculture step in the diagnostic workflow, they then applied TFF to 
separation of bacteria from whole blood. Studies confirmed the feasibility of this application by 
processing nine types of microorganisms grown in standard aerobic media. Results showed a 
significantly reduced workflow timeline of 32 hours from culture inoculation (i.e. blood draw) to 
accurate ID/AST results, allowing movement into the technical development phase. This being 
said, parameters for PBC processing were selected based upon the original intent (plasma 
separation) of the TFF technology with a limited battery of organisms and media types. This 
chapter details results from an expanded test list of organisms across more than one media type, 
as well as methods and results of processing characterization and optimization. Overall, the scope 
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of this project aimed to understand the impact of various factors of the blood culture input and 
sample processing workflow on ID/AST. 
EXPERIMENTAL METHODS 
 Understanding the impact of processing parameters on downstream testing results is key 
to optimizing bacterial recovery for accurate ID/AST. We conducted a study on an expanded 
repertoire of organisms and media types to set a baseline of technology performance for 
downstream testing. From this study, we targeted problematic areas within the workflow. This 
allowed us to characterize and optimize various parameters in order to increase processing 
efficiency and yield a more suitable output for ID/AST. 
PBC Processing Workflow 
Figure 4 shows the general workflow for processing a PBC.  
 
Figure 4: General Workflow for Separation of Bacteria from a Positive Blood Culture (Positive Blood Culture 
Processing). Step 1: 5mL aliquot drawn from PBC. Step 2: Sample run through 3.0µm filter and washed with 5mL 
DI water to exclude blood background. Step 3: 2mL of BD BACTEC Lytic Anaerobic media added to permeate. Step 
4: Sample run through 0.4µm filter to exclude plasma and cellular debris, and washed with 5mL DI water. Step 5: 




After inverting the PBC several times to ensure a well-mixed culture, a 5mL aliquot was drawn 
from the PBC bottle using a 5mL syringe and 18G needle. The flowrate of the peristaltic pump 
and pressure of the vacuum pump were set to 25mL/min and -70kPa, respectively, and the 
apparatus was turned on. The PBC aliquot was dispensed into the apparatus and run through a 3µm 
filter in order to exclude the blood background. A 5mL deionized (DI) water wash was applied to 
the sample as it ran through in order to prevent buildup on the membrane and aid flow of bacteria 
through the pores. We collected the permeate of this step once the entire blood background was 
visibly excluded, or with about 1mL of retentate remaining. 2mL of lytic anaerobic media were 
then added to the permeate in order to lyse any blood cells that passed through the filter. This 
sample was run through a 0.4µm filter using the same pressure and flowrate in order to further 
isolate the bacteria from plasma and remaining cellular debris. Another 5mL deionized (DI) water 
wash was applied to aid filtration. After completing the wash, the sample was collected in a 2mL 
Eppendorf tube and analyzed the output using downstream tests.  
Baseline Data 
 We collected downstream testing data in order to set a baseline for initial performance 
across a larger battery of microorganisms and media than previous studies. We processed thirty 
strains of bacteria (see Appendix 1, Table A1) grown in each of the following BACTEC media: 
Standard Aerobic, Lytic Anaerobic, and PLUS Aerobic.  
Initial performance assessments included analysis of the percent recovery of bacteria from 
the original PBC, Phoenix AST results compared to the reference method (purity plate), and 
capability and accuracy of ID using MALDI-ToF MS. Figure 5 illustrates the experimental setup 




Figure 5: Workflow of Baseline Testing and General Protocol for Downstream Testing. We spiked 
BACTEC Blood Culture Media bottles with 40mL and 10-100 CFU for each microorganism and media type. 
Blood cultures incubated overnight in BACTEC FX instruments. After the instrument detected bacterial 
growth, we removed the blood cultures and processed them through both the reference and experimental 
methods. For the reference method, we removed an aliquot of PBC for a subculture, which we incubated for 
24 hours before performing plate counts and Phoenix AST. For the experimental method, we processed the 
PBC through the standard processing workflow, plated the output tube for plate counts, and ran MALDI and 
Phoenix AST directly from the output tube. For deviations from the standard PBC processing method, see 
subsequent experimental methods. 
Simulation of Positive Blood Culture. We simulated a positive blood culture from a sepsis patient 
by inoculating BACTEC blood culture bottles with 10 mL of blood and 10-100 CFU. In order to 
do so, for each strain of bacteria, we made a subculture from a QC plate 24 hours prior to 
inoculation. From this subculture, we created a 1 McFarland solution with sterile saline and made 
100-fold serial dilutions using standard aerobic media to reach a dilution factor of 10-6. We then 
inoculated a new BACTEC blood culture bottle of the specified media type with 10mL of blood 
(warmed to room temperature) followed by 0.1mL of the 10-6 dilution sample. We incubated the 
blood cultures overnight in a BD BACTEC FX instrument. 
Positive Blood Culture Processing. We followed the standard sample processing workflow shown 
in Figure 4.  
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Cell Plating and Plate Counts. Prior to processing, we plated an aliquot of the PBC for the 
reference method. We also plated the output tube from processing. For plating and counting of all 
samples, we used the dilution scheme and calculations shown in Appendix 1, Table A1.2. 
AST Processing using Phoenix. We processed both the experimental and reference method samples 
for AST according to the BD Phoenix System User’s Manual protocol11. Briefly, we used Phoenix 
ID broth to make a 0.5-0.6 McFarland for each sample. We then added 42µL of AST indicator and 
25µL of the 0.5-0.6 McFarland to a Phoenix AST broth tube (8mL) and inoculated an AST-only 
panel specific to the type of bacteria. For the experimental method, if the standard 0.5-0.6 
McFarland could not be achieved for AST panel inoculation, we adjusted the sample to a 0.25-0.3 
McFarland using Phoenix ID broth and added 50µL to the AST broth. 
Identification using MALDI-ToF MS. We used a MALDI Biotyper (Bruker Daltonics) to identify 
all samples throughout the entirety of this project. For each plate processed, we included two spots 
of Bacterial Test Standard (BTS) for a performance control. BTS contains an extract of E. coli 
DH5 alpha and two other high molecular weight proteins, mixed with a standard solvent (50% 
acetonitrile, 47.5% water, 2.5% trifluoroacetic acid)12, 13. This mixture yields a peptide and protein 
profile that covers the entire range of spectra identified by the instrument, thus serving as a quality 
control standard. For samples processed through the experimental method, we pipetted two 1µL 
layers directly from the output tube onto a spot on the stainless steel MALDI target plate. On top 
of each test spot, we pipetted 1µL of formic acid and incubated the plate at 35°C until the spots 
dried. Finally, we pipetted 1µL of matrix on each test spot, allowed them to dry at room 




Filtration of Resin Beads from PLUS Aerobic PBCs  
BACTEC PLUS Aerobic blood culture bottles contain resin beads large enough to clog the 
pores of the TEM filters, effectively inhibiting filtration of bacteria. In order to prevent this, we 
used a 100µm mesh filter to remove as many resin beads as possible from the PBC before drawing 
an aliquot for filtration. To confirm no bacterial loss during this filtration, we spiked four PLUS 
Aerobic culture bottles, two with wild type E. coli and two with wild type S. aureus, according to 
the baseline study workflow method and incubated overnight. Once the cultures turned positive, 
we used a 100µm mesh filter held in place with a syringe filter holder to filter the PBC into a 
vacutainer. For each bacterium, we collected three BD vacutainers of sample, processed each 
vacutainer through the PBC processing workflow, and plated the outputs according to the dilution 
scheme described in the baseline study methods.  
Optimization of Lysis Step 
Previously, the material and amount of lytic agent used was selected based upon the amount 
of saponin present in BACTEC Lytic Anaerobic media (2mL of 2.6g/L saponin). In order to 
determine the optimal amount of saponin and eliminate the addition of unnecessary media 
components into the processed sample, we compared the ability of varying concentrations of 
saponin water to yield accurate downstream results. We processed five PBCs spiked with wildtype 
E. coli. For each sample, we applied a different concentration of lytic agent. We used 2mL of lytic 
anaerobic media as a positive control, 2mL 1.3g/L saponin, 2mL 2.6g/L saponin, 2mL 3.9g/L 
saponin, and 2mL 5.2g/L saponin. We used identification scores from MALDI to analyze the 




Characterization of Flux across Filter over Time 
 Studies show that over time, a cake layer of filtrate forms on the top of filter membranes 
used in dead-end filtration, blocking material from flowing through the pores13, 14. Although this 
buildup is shown to decrease by switching to TFF, we hypothesized that any cake layer formation 
on the filter causes a decrease in the flux across the filter over time, thus limiting the collection 
and concentration of bacteria from the original sample. To characterize the flux across our filter 
membranes, we used a scale to measure the weight of the retentate over time. We used Matlab to 
collect the scale readings and convert them to volume before generating a plot of flux over time. 
We collected data for flux across both the 3µm and 0.4 µm filters for S. epidermidis (ATCC 14990), 
E. faecalis (ATCC 51299), S. aureus (CDC Challenge 2052), and S. lugdunesis (clinical). 
Effects of Increased Pore Size on Downstream Testing Results 
We hypothesized that increasing the pore size of the first filtration step increases the flux 
of the sample across the membrane, thus increasing recovery of bacteria and improving 
downstream testing results. We quantified the passage of red blood cells through various filter pore 
sizes in order to determine the tolerance of downstream tests to red blood cells and blood 
background. 
Bacterial Recovery. While processing the PLUS Aerobic blood cultures during the baseline study, 
we processed all samples through a 5µm first stage filtration and a 0.8µm second stage, in addition 
to the 3µm/0.4µm filtration scheme used for all media types. We followed the same baseline study 
and PBC processing workflows and collected the same data. 
Passage of Red Blood Cells. We used a hemocytometer to quantify red blood cell passage through 
filters of varying pore sizes. We incubated 10mL of blood in 40mL Standard Aerobic media 
overnight in a BACTEC to simulate a negative blood culture (NBC). We then processed three 5mL 
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aliquots of the NBC through a 5µm filter. We made three 10-fold serial dilutions from each 
permeate, as well as from a 5mL aliquot of the NBC (unfiltered). We pipetted 10µL of each 10-3 
dilution onto a bright line hemocytometer (AO Scientific Instruments) and counted the number of 
red blood cells using an inverted microscope. 
RESULTS 
 Due to the large number of samples processed during the baseline study, we encountered a 
number of difficulties with the processing of certain media types and bacteria. We characterized 
and adjusted steps of the PBC processing workflow in order to yield accurate results for the 
baseline study. From this study we found that overall, Gram negative bacteria perform well across 
all media types in terms of filtration, AST, and MALDI ID performance. Gram positive bacteria, 
specifically Staphylococci, proved problematic in yielding accurate ID/AST results across all 
media types. We attributed this to a lack of bacteria in the output due to a combination of cake 
layer formation on the membrane surface, which impedes filtration, and the clumping nature of 
Gram positive bacteria. After characterizing the flux across filter membranes, we found that over 
time flux remains relatively constant for larger pores, while smaller pores show a decrease in flux. 
This suggests a smaller cake buildup and higher filtration rate as pore size is increased. 
Furthermore, we found that increasing the pore size allows recovery of more Gram positive 
bacteria and improves ID/AST results. 
PBC Processing Workflow 
 During the initial phases of the baseline study, we encountered inaccurate downstream 
results. Thus, we targeted certain processing steps in order to improve the quality of the output 
tube for more accurate ID/AST results. 
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Wash Steps. While processing the first round of PBCs (Standard Aerobic media), we observed a 
dark pink to red color in the permeate from the first filtration step. Since this initial step serves to 
separate the blood background out from the sample, it should appear relatively clear with little to 
no red coloring. We hypothesized that the discoloration resulted from premature lysis of red blood 
cells due to an increase in osmotic pressure caused by immediate washing of the sample with 5mL 
DI water. We began washing samples with 5mL of sterile saline rather than DI water. Furthermore, 
we processed samples through the workflow, diluting the PBC aliquot upfront with 5mL of saline 
before filtering the sample rather than applying a wash during the first filtration step. This cleaned 
up the samples significantly and the permeate appeared relatively colorless. 
Optimization of Lysis Step. We targeted the lysis step of PBC processing in order to further 
eliminate as much blood background as possible from the final output sample. Since residual blood 
background in the output is most likely to interfere with proper ID of bacteria, we compared 
MALDI ID scores for each lytic agent in order to determine the optimal concentration of saponin 
(Figure 6). We used Lytic Anaerobic Media as a positive control. The highest average scores came 
from the Lytic Anaerobic media (2.36) and 2.6g/L saponin (2.31), which is the concentration of 
saponin present in the lytic media. The 1.3g/L saponin yielded an average score of <1.70, i.e. not 
a reliable ID. While the 3.9g/L saponin yielded a score with species-level accuracy, it was over 
0.3 points lower than the lytic media. The 5.2g/L saponin yielded about the same score as 2.6g/L 




Figure 6: First Match MALDI ID Scores for Processed E. coli PBCs using Varying Lytic Agents. We 
processed a PBC containing E. coli (ATCC 25922) using Lytic Anaerobic media (postiive control) and varying 
concentrations of saponin as lytic agents. We processed duplicates for each lytic agent and averaged the first 
match scores, shown above.  
This indicates that the lowest concentration of saponin is insufficient in removing enough 
background from the sample and thus the final output likely contains material that interferes with 
ID of bacteria. Furthermore, while saponin concentrations of 3.9 and 5.2g/L yield sufficient results, 
we moved forward with the 2.6g/L saponin in order to minimize the amount of material used. 
 In order to further confirm that 2.6g/L saponin water performs the same or better than the 
original lytic agent, we processed samples from the baseline study using both BACTEC Lytic 
Anaerobic media and 2.6g/L saponin water. We compared the MALDI scores of each lytic agent 
by performing a two-sample t-test, which yielded average ID scores of 2.2398 and 2.2068 for 



























Figure 7: Distribution of First Match MALDI Scores of Baseline Test Isolates using Lytic Anaerobic 
Media vs. 2.6g/L Saponin as a Lytic Agent.  We processed 2 aliquots each from 5 PBCs from the baseline 
test microorganisms (E. coli, P. aeruginosa, E. faecalis, S. aureus, and S. pneumoniae) using Lytic Anerobic 
Media and 2.6g/L saponin for lytic agents. We performed a two-sample t-test in order to observe any significant 
difference in the MALDI ID scores from using media versus saponin. We found no significant difference as 
p>0.05. 
With these results, we confirmed that at a significance level of 0.05, there is no significant 
difference between using 2.6g/L saponin versus lytic media. Furthermore, both lytic agents yielded 
average scores sufficient for a species level match (≥2.0), signifying their abilities to lyse enough 
blood background for accurate ID. Thus, we moved forward with using 2.6g/L saponin in place of 
lytic media during PBC processing. 
Processing of Lytic Anaerobic PBCs. We also observed pink-red discoloration in the output tubes 
of the Lytic Anaerobic PBCs and subsequent incapability of accurate MALDI ID for these samples. 
We hypothesized that this discoloration stemmed from lysis of blood cells by the saponin present 
in the lytic media. We ran five samples through the full PBC processing workflow, applying as 
much DI water as necessary to yield a cleaner output sample. We did not observe any significant 
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increase in output sample clarity until we used at least 10mL of DI water during the second wash 
step. In order to maintain short processing time, we did not implement an increased wash volume. 
Instead, we allowed the sample to run almost entirely through the second filtration step before 
slowly applying the 5mL wash. This improved sample clarity from application of the DI water 
wash at the beginning of the second filtration step. 
Removal of Resin Beads from PLUS Aerobic PBCs. We drew three aliquots from each PBC 
through a syringe filter, and averaged the plate counts over each microorganism. The E. coli 
samples averaged a 10% increase after resin bead removal while the S. aureus samples averaged 
a 25% loss in bacteria (Figure 8).  
 
Figure 8: Loss of Bacteria from Filtration of Resin Beads from PLUS Aerobic PBC. We used a syringe filter 
to remove the resin beads from PLUS Aerobic PBCs in order to prevent membrane fouling during PBC processing. 
We plated two separate PBCs containing E. coli (ATCC 25922) and S. aureus (ATCC 29213) after the BACTEC 





















Even with a 25% loss of bacteria from the S. aureus sample, the difference remains less than 
half of a log from the original PBC. Moreover, we recorded values on the order of 8x107 
CFU/mL for S. aureus grown in Standard Aerobic and Lytic Anaerobic media during the 
baseline study. In order to verify that filtering resin beads prior to processing does not 
significantly affect the number of viable bacteria, we performed a two-sample t-test and yielded 
a p-value of 0.895. For a significance level of 0.05, this confirmed that removing resin beads 
from PLUS Aerobic samples leaves the PBC unaltered from its original state while making it 
more suitable for processing. We implemented this procedure for all PLUS Aerobic samples 
processed during the baseline study. 
Baseline Performance Data 
 We collected and analyzed data to evaluate filtration performance, capability and accuracy 
of ID by MALDI, and accuracy of Phoenix AST compared to the reference method.  
Filtration Performance. For each bacteria and media type, we averaged the plate counts of the 
original PBC and output tube across strains (Appendix 1, Figure A1.1). We compared these values 
by calculating the percent recovery for each microorganism in each media type. Overall, we 
recovered an average of 80.0%, 93.4%, and 98.5% of bacteria from Gram negative and 48.3%, 
79.5%, and 76.8% of bacteria from Gram Positive PBCs grown in Standard Aerobic, Lytic 
Anaerobic, and PLUS Aerobic media, respectively (Figure 9). Gram negative microorganisms A. 
baumanii and P. aeruginosa did not grow in Lytic Anaerobic media due to their aerobic nature, 





Figure 9: Total CFU in PBC vs. Output Tube for Gram Negative Bacteria for Each Media Type. We 
averaged the PBC and output plate counts across the strains of each microorganism for each type of media, 
and then used these counts to calculate the percent recovery of bacteria from filtration. (A) Standard Aerobic 
Media. (B) Lytic Anaerobic Media. (Note: BACTEC detected no growth for A. baumanii and P. 
aeruginosa in Lytic Anaerobic media due to their aerobic nature). (C) PLUS Aerobic Media. (D) Percent 
recovery per media type for each Gram negative bacteria. 
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In general, the Gram positive bacteria—specifically Staphylococci—yielded a much lower percent 
recovery than the Gram negative bacteria. Additionally, bacteria grown in Lytic Anaerobic and 
PLUS Aerobic yielded higher percent recoveries (overall averages of 85.9% and 88.8%, 
respectively) than Standard Aerobic media (overall average of 65.2%). This being said, for most 
bacteria with a lower than average percent recovery, the difference in total CFU from PBC to 
output remained within one log and greater than 108 CFU. Staphylococci persisted as an exception. 
In order to qualify low percent recoveries and better understand an acceptable lower limit, we 
looked further to the results of ID and AST. 
Phoenix AST Performance. We compared Phoenix AST results of the output samples to results of 
an isolate from the original PBC. We used the MICs from the original PBC isolate as a reference 
and calculated the difference in doubling dilutions of the output sample from the reference. Across 
all media types and microorganisms 97.3% of all samples gave an essential agreement. Table 1 
displays essential agreement data for each microorganism in each media type.  
Table 1: Phoenix AST Results for Each Microorganism and Media Type. 
Microorganism # of Strains 
Standard Aerobic Lytic Anaerobic PLUS Aerobic 
Total n Essential Total n Essential Total n Essential 
Gram Negative 16 463 95.90% 347 98.85% 463 99.14% 
A. baumanii 2 58 98.28% No BACTEC growth N/A 58 96.55% 
E. cloacae 2 58 98.28% 58 96.55% 58 100.00% 
E. coli    3 87 82.76% 87 100.00% 87 100.00% 
K. pneumoniae 3 87 100.00% 87 98.85% 87 98.85% 
P. mirabilis 2 58 100.00% 58 100.00% 58 100.00% 
P. aeruginosa     2 58 96.55% No BACTEC growth N/A 58 100.00% 
S. marcescens  2 57 100.00% 57 98.25% 57 98.25% 
Gram Positive 14 374 89.84% 436 83.03% 605 89.09% 
E. faecalis 2 68 95.59% 68 95.59% 68 95.59% 
E. faecium 2 34 100.00% 68 100.00% 102 94.12% 
S. aureus 4 136 99.26% 136 97.79% 204 98.04% 
S. epidermidis  2 68 50.00% 68 0.00% 101 49.50% 
S. lugdunensis   1 34 100.00% 34 100.00% 34 100.00% 
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S. saprophyticus  1 34 100.00% 34 100.00% 68 100.00% 
S. pneumoniae 2 *not tested 
*not 
tested 28 100.00% 28 92.86% 
Overall Total 30 837 93.19% 783 90.04% 1068 93.45% 
Gram negative bacteria yielded concordant results with the reference method across all media 
types. For gram positive bacteria, S. epidermidis posed the biggest challenge. For all three media 
types, the output of the wildtype strain PBC did not grow in the AST panel. Additionally, the 
wildtype isolates from PLUS Aerobic media that we used as a reference did not grow in the panel. 
We reran both the reference and the output through AST, but again yielded no growth. No growth 
from reference samples most likely signifies a contaminated or old QC plate since the sample was 
unprocessed. For S. epidermidis PBCs grown in lytic media, neither the outputs from the wildtype 
nor resistant strains grew in AST. The remaining Staphylococci did not pose as much of a challenge 
for AST, as they all yielded at least 97.79% concordance with the reference method. 
MALDI ID Performance. We collected identification data for 91 outputs from PBC processing 
across three media types (Table 2). We grouped isolate scores into three levels of accuracy based 
upon recommendations from Bruker. Of the 46 Gram negative isolates tested, 93.5% (n=43) 
identified correctly to the genus level, 91.3% (n=42) to the species level, and 6.5% (n=3) yielded 
no reliable identification. For the 45 Gram positive isolates,71.1% (n=32) identified correctly to 
the genus level, 53.3% (n=24) to the species level, and 28.9% (n=13) yielded an unreliable 
identification. 
Table 2: Performance of MALDI Biotyper for ID of Each Microorganism (Total across Strains and Media 
Types). 
Microorganism Total Number of Isolates Accuracy of ID, n (%) 
Species Correct Genus Correct No ID 
Gram Negative 46 42 (91.3%) 43 (93.5%) 3 (6.5%) 
Acinetobacter baumannii 4 4 (100%) 4 (100%) 0 (0%) 
Enterobacter cloacae 6 5 (83.3%) 6 (100%) 0 (0%) 
Escherichia coli 10 9 (90.0%) 9 (90.0%) 1 (10.0%) 
Klebsiella pneumoniae 9 8 (88.9%) 8 (88.9%) 1 (11.1%) 
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Proteus mirabilis 6 6 (100%) 6 (100%) 0 (0%) 
Serratia marcescens 7 6 (85.7%) 6 (85.7%) 1 (14.3%) 
Pseudomonas aeruginosa 4 4 (100%) 4 (100%) 0 (0%) 
Gram Positive 45 24 (53.3%) 32 (71.1%) 13 (28.9%) 
Staphylococcus aureus 13 5 (38.5%) 9 (69.2%) 4 (30.7%) 
Staphylococcus epidermidis 5 0 (0.0%) 1 (20.0%) 4 (80.0%) 
Staphylococcus lugdunensis 3 0 (0%) 1 (33.3%) 2 (66.7%) 
Staphylococcus saprophyticus 5 2 (40.0%) 3 (60.0%) 2 (40.0%) 
Enterococcus faecium 7 6 (85.7%) 6 (85.7%) 1 (14.3%) 
Enterococcus faecalis 6 6 (100%) 6 (100%) 0 (0%) 
Streptococcus pneumoniae 6 5 (83.3%) 6 (100%) 0 (0%) 
Grand Total 91 66 (72.5%) 75 (82.4%) 16 (17.6%) 
For isolates that yielded “No Peaks Found” (i.e. a score between 0 and 1.70, exclusive) upon the 
initial run, we added layers of sample as necessary in order to determine if the cause stemmed 
from lack of bacteria. We added up to three additional 1µL layers. Overall, MALDI identified 
Gram negative microorganisms more accurately than Gram positive microorganisms. 
Staphylococci strains in particular yielded poor ID accuracy, with 46.2% (n=12) yielding no 
reliable identification.  
Looking further at MALDI accuracy across media types, we saw accurate identification 
for all Gram negative samples in both Standard and PLUS Aerobic media; however, 21% (n=3) of 
the strains grown in Lytic Anaerobic media yielded no reliable identification (Figure10 A). For 
Gram positive bacteria, 54% (n=7) grown in Standard Aerobic, 78% (n=11) grown in Lytic 
Anaerobic, and 77% (n=14) grown in PLUS Aerobic media identified correctly to the genus level 





Figure 10: Distribution of MALDI ID Accuracy per Media Type. (A) Accuracy of ID per media type 
for Gram negative microorganisms (B) Accuracy of ID per media type for Gram positive microorganisms. 
In general, we experienced difficulty accurately identifying the PBC processing outputs of Gram 
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Characterization of Flux Across the Membrane over Time 
 We hypothesized that the difficulties with MALDI ID and Phoenix AST stems largely from 
a lack of viable bacteria in the output due to poor flow across and through the membrane. Thus, 
we characterized the flux across the filter membrane in order to understand any changes in the 
level of filtration over time. We filtered PBCs through membranes with 3µm pores and membranes 
with 0.4µm pores. We calculated the flux across the filter membrane from the volume of permeate 





Figure 11: PBC Flux Over Time Across 3µm and 0.4µm filters. We filtered PBCs of S. epidermidis (A, B), S. 
aureus (C, D), E. faecalis (E, F), and S. lugdunesis (G, H) through 3µm (A, C, E, G) and 0.4µm filters (B, D, F, 
H). We measured the volume of permeate from each filter over time and then calculated and plotted the flux over 
time. We averaged the flux for each sample, shown in the red dashed line on each graph. 
For the 3µm filtration, samples took no longer than 2 minutes to completely filter. Flux decreased 
steadily and relatively slowly over time for all samples except E. faecalis, which increased by 
about 40µL/s throughout filtration. For the 0.4µm filtration, the flux for all samples decreased 
rapidly within the first 30 seconds to minute followed by a steady decrease similar to that of the 
first stage. The flux across the 3µm filter averaged 66.65µL/s for all samples while the flux across 
the 0.4µm filter averaged 52.75µL/s, demonstrating a higher flux for larger pore sizes. 
 While processing single aliquots allowed us to characterize flux across the membrane over 
time, we sought to determine the point at which flux remains constant across the filter membrane. 
Thus, we performed a stress test for both the 3µm and 0.4µm filter. We used the same setup; 
however, rather than running one aliquot of PBC, we continued to filter PBCs through the same 
filter until we observed constant flux across the membrane. The 3µm membrane filtered 63ml over 
9.5 minutes while the 0.4µm membrane filtered 58mL over 68.5 minutes (Figure 12). We stopped 





Figure 12: Stress Test of Flux Over Time Across 3µm and 0.4µm Pores. We continued filtering PBCs 
through the same 3µm (A) and 0.4µm (B) filters in order to observe a point of constant flux. We measured 
the volume over time (orange line) and then calculated the flux over time. We stopped filtering PBCs 
through the 0.4µm after 68.5 minutes due to time and sample constraints. 
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For the 0.4µm filtration, flux increased sharply at the start of processing before starting a slow 
decline. While the decline remained consistent with the single aliquots we tested, the overall flux 
throughout the filtration process started at and decreased to a much lower value. This signifies 
potential buildup of a cake layer that ultimately prevents remaining sample from filtering. The flux 
during the 3µm filtration increased by about 150µL/s over 3 minutes before starting to decrease. 
Although this differed from the single aliquot samples, it is possible that the short time period over 
which we collected that data would not reveal this behavior. 
Effect of Increasing Filter Pore Size 
After observing increased flux with a larger pore size, we sought to improve bacterial 
recovery by increasing the first stage filtration pore size from 3µm to 5µm. We processed the thirty 
bacterial strains grown in PLUS Aerobic media through a filter scheme of 5µm/0.8µm and 
compared downstream test results to the results of the 3µm/0.4µm filter scheme. Prior to gathering 
performance data, we quantified red blood cell passage through varying pore sizes in order to 
determine feasibility and understand the effect of red blood cell passage on future downstream 
testing performance. 
Red Blood Cell Passage. We compared the percent passage of red blood cells from an NBC 
through a 5µm filter to the percent passage through 3µm, 2 µm, and 1 µm. 34.9% of red blood 
cells passed through the 5µm filter while 10.2%, 1.4%, and 0.1% passed through the 3µm, 2 µm, 




Figure 13: Percent Passage of Red Blood Cells from a Negative Blood Culture through Varying Filter 
Pore Sizes. We filtered aliquots of a negative blood culture (NBC) through 5µm, 3µm, 2 µm, and 1 µm 
filters. We quantified red blood cell (RBC) passage using a hemocytometer. We calculated percent passage 
using the original number of RBCs in the NBC. 
Each increase in pore size resulted in about a tenfold increase in total RBC passage. Although the 
percent passage of RBCs through the 5µm filter was triple the percent passage through the 3µm 
filter, we moved forward with testing this increase in pore size. The results of this experiment 
allowed us to determine the effect of increased RBC passage, as well as prioritize maximization 
of bacterial passage versus minimization of RBC passage. 
Recovery of Bacteria. We averaged the plate counts from PLUS Aerobic PBCs processed through 
a 5µm/0.8µm filtration scheme and compared the results to those processed through the 
3µm/0.4µm scheme. For Gram negative bacteria, the 5µm filter recovered an average of 5.71x109 
CFU versus 6.88x109 CFU recovered from the 3µm filter. The 3µm filter recovered more total 
CFU from the PBC for all Gram negative PBCs (Figure 14 A). For Gram positive bacteria, the 



























filter. The larger filter scheme recovered more CFU from the PBCs of S. aureus, S. epidermidis, 
and S. lugdunensis (Figure 14 B). 
 
Figure 14: Total CFU in PLUS Aerobic PBCs vs. Outputs from 3.0µm and 5.0µm Filtration 
Schemes. We processed two aliquots per strain of microorganism, one through a 3µm/0.4µm scheme and 
one through a 5µm/0.8µm scheme. We averaged plate counts across strains before and after processing. 
We compared total CFU in the output from each filter scheme to one another and to the original PBC. We 
plotted these values for Gram negative bacteria (A) and Gram positive bacteria (B). 
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Overall for Gram negative bacteria, the total CFU recovered from a larger pore size remained 
relatively the same as a smaller pore size. Gram positive bacteria, specifically Staphylococci, saw 
an increase in total CFU recovered with a larger filter size. We recovered nearly tenfold the number 
of bacteria from the larger filter compared to the smaller filter (5.39x108 vs. 7.95x107, respectively), 
which improved percent recovery from 3.9% to 24.1%. Furthermore, we recovered 5.39x108 CFU 
of S. epidermidis from the larger filter versus 4.42x107 CFU from the smaller filter—a shift from 
24.0% to 111.9% recovery (Figure 15). 
 
Figure 15: Percent Recovery from PLUS Aerobic PBCs Processed through 3.0µm and 5.0µm Filtration 
Schemes. We calculated percent recoveries for each strain using the total CFU from the original PBC and outputs. 
We averaged the percent recoveries across strains of Gram negative and Gram positive organisms, as well as each 
species of Staphylococci. We focused on Staphylococci due to the low percent recovery from the original filter 
size and its inability to generate consistent ID/AST results. 
While the percent recovery of Gram negative bacteria decreased overall, the number of total CFU 
recovered from the larger filter remained much the same as the original filter size. Additionally, 
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concordant with the reference method than Gram positive bacteria. Since recovery of Gram 
positive bacteria—and especially Staphylococci—increased with a larger pore size, we moved 
forward with downstream testing in order to determine if more bacteria improve ID/AST results. 
Phoenix AST Performance. We used the same reference PBC AST results for samples filtered 
through both the 3µm and the 5µm schemes. For all Gram negative bacteria, the 5µm scheme 
yielded nearly equal results as the 3µm scheme, averaging 99.35% of MICs in essential agreement 
versus 99.14% of MICs for the 3µm (Table 3). For Gram positive bacteria, 90.02% of MICs 
yielded an essential agreement for the 5µm scheme versus 89.09% for the 3µm. While the percent 
of Gram positive samples with no AST growth remained the same across both filter sizes, the 
percentages of S. epidermidis and S. pneumoniae both decreased from 33.66% to 25.19% and 7.14% 
to 0%, respectively.  
Table 3: Phoenix AST Results for PLUS Aerobic PBCs Filtered through 3µm vs. 5µm Schemes. 
Organism # of Strains 
3 5 
Total 





Gram Negative 16 463 99.14% 0.00% 463 99.35% 0.00% 
A. baumanii 2 58 96.55% 0.00% 58 98.28% 0.00% 
E. cloacae 2 58 100.00% 0.00% 58 100.00% 0.00% 
E. coli 3 87 100.00% 0.00% 87 100.00% 0.00% 
K. pneumoniae 3 87 98.85% 0.00% 87 98.85% 0.00% 
P. mirabilis 2 58 100.00% 0.00% 58 100.00% 0.00% 
P. aeruginosa 2 58 100.00% 0.00% 58 100.00% 0.00% 
S. marcescens 2 57 98.25% 0.00% 57 98.25% 0.00% 
Gram Positive 14 605 89.09% 5.95% 571 90.02% 5.95% 
E. faecalis 2 68 95.59% 0.00% 68 95.59% 0.00% 
E. faecium 2 102 94.12% 0.00% 102 100.00% 0.00% 
S. aureus 4 204 98.04% 0.00% 170 98.24% 0.00% 
S. epidermidis 2 101 49.50% 33.66% 135 62.22% 25.19% 
S. lugdunensis 1 34 100.00% 0.00% 34 100.00% 0.00% 
S. 
saprophyticus 1 68 100.00% 0.00% 34 100.00% 0.00% 
S. pneumoniae 2 28 92.86% 7.14% 28 100.00% 0.00% 
Overall Total 30 1068 93.45% 3.37% 1034 94.20% 3.29% 
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Overall, the increase in filter size did not yield significantly more accurate AST results; however, 
the problematic S. epidermidis strains saw an increase in both exact and essential agreements by 
over 10%. Although 62.2% of MICs remains well below concordant with the reference standard, 
the corresponding increase in total CFU recovered by switching to a larger filter size signifies that 
more bacteria aids in accuracy of AST results. Furthermore, an increase in passage of RBCs 
through the larger filter may contribute to the turbidity of the output sample, impeding growth in 
certain AST wells and effecting the overall MIC for certain drugs. 
MALDI ID Performance. We compared MALDI scores for PLUS Aerobic PBCs filtered through 
a 3µm scheme versus a 5µm filter scheme. Overall, filtering through a larger pore size yielded 
more accurate identification of bacteria with 96.77% (n=30) of all samples identifiable to at least 
the genus level versus 88.89% (n=28) from the 3µm scheme (Figure 16 A). Gram negative bacteria 
remained consistent across both filter sizes, yielding accuracy to the species level for 100% of 
samples (Figure 16 B). Gram positive bacteria yielded at least genus-level identification accuracy 
for 93.33% (n=14) of samples filtered through the larger pore size versus 80.00% (n=12) of 
samples filtered through the smaller pores (Figure 16 C). Within the Gram positive samples, E. 
faecalis, E. faecium, and S. pneumoniae yielded 100% identification accuracy to the species level 
for both filter sizes. For the remaining bacteria (i.e. Staphylococci), 87.5% of samples identified 
at least to the genus level with only one sample (S. aureus) yielding no reliable identification 





Figure 16: Distribution of MALDI Scores for PLUS Aerobic PBCs filtered through 3µm vs. 5µm Schemes. 
We compared the accuracy of MALDI identification for samples filtered through a 3µm versus 5µm filter scheme. 
We grouped scores based upon recommendations from Bruker. We looked at the overall score distribution across 
all bacteria (A) before narrowing the distribution to only Gram negative (B) and positive (C) bacteria, and finally 
Staphylococci (D). 
From these results, we see that filtering samples through a larger pore size increases accuracy of 
identification, most likely due to an increase in bacteria. Moreover, this increase did not affect 
identification of Gram negative bacteria. This implies that the additional amount of bacterial 
passage through the filter outweighs any impeding effects of RBC passage. Although increasing 
filter pore size looks promising, Staphylococci strains still propose a challenge for accurate 
ID/AST results. 
DISCUSSION 
 Although we successfully adjusted processing parameters during the baseline study to 
generate as accurate results as possible, there remains much room for improvement for PBC 
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processing. Difficulties yielding accurate results for PBCs grown in lytic media and Gram positive 
PBCs show that excess blood background and lack of bacteria in the output play key roles in 
ID/AST results. While the optimal balance between more bacteria and less blood background 
remains relatively uncertain, our preliminary results suggest that increasing filter pore size yields 
better ID/AST results. 
PBC Processing Workflow 
 The general workflow for PBC processing remained consistent with its original protocol 
as it proved relatively robust across media and bacteria types. This being said, we made several 
adjustments to the workflow depending upon the PBC media type. A major adjustment included 
pre-filtering of resin beads PLUS Aerobic PBCs, necessitating an extra step in the workflow. 
Additionally, the material, volume, and timing of the wash step became critical for all media types, 
but mainly Lytic Anaerobic. Proper application of the washes avoids premature cell lysis and aids 
sample flow across the TEM to minimize cake buildup. While we easily made these adjustments 
to our benchtop technology, development of next generation technology must keep in mind and 
accommodate for the necessary deviations for various media types. 
In order to successfully standardize the workflow and eventually automate the system, 
limits for processing time, wash volume, and the required hands-on time must be defined and 
remain consistent across all media types. Alternatively, a separate device may be designed for each 
specialty media types. For instance, a device for PLUS aerobic PBCs that includes an additional 
filtration system, or a device for Lytic Anaerobic PBCs that includes a higher wash volume. Still, 
the PBC processing workflow remains relatively straightforward in its current state with 




 As previously mentioned, PBC processing showed robustness across all media types and 
most microorganisms. This being said, Staphylococci yielded problems for all aspects of the 
baseline study, most likely due to clumping of colonies and subsequent inability to filter. A 
microfluidic device that physically separates clumps of colonies prior to filtration has potential to 
increase percent recovery for these strains and collect more bacteria. The number of bacteria 
required from the output for downstream testing still needs to be defined, but preliminary results 
showed that more bacteria and higher percent recovery yields better results. 
 PBC processing yields a variable percent recovery of bacteria from the original PBC, 
especially across media types. However, a majority of the strains processed yielded substantially 
high percent recoveries, again with the exception of Staphylococci. For most cases that yielded 
greater than 100% recovery from the PBC, this can be attributed to a lag between the time of the 
initial plate count and initiation of PBC processing, allowing for further growth. Furthermore, we 
performed plate counts by hand and while we strived to be as accurate as possible, the margin of 
error remains very large. Another explanation for generating more CFU in the output than the PBC 
is the potential of bacterial concentration outweighing any bacterial loss, thus indicating high filter 
performance.  
 While percent recovery is important for assessment of filter performance, it can be 
misleading and a low percent recovery is not necessarily an indicator of poor downstream test 
results. In cases of low percent recovery, it is important to additionally consider the total CFU in 
the output. Looking at a low percent recovery with an output CFU on the order of 108 or higher 
tells us that while we do have ample bacteria for downstream testing, the filter is operating 
inefficiently and warrants the need for further optimization and improvement. Thus, the number 
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of total CFU in the output tube must also be considered when defining a lower limit for percent 
recovery and the necessary number of bacteria required for ID/AST.  
 S. epidermidis remained the single bacterium yielding discordant AST results across all 
media types. Again, this most likely stemmed from lack of bacteria in the output. This being said, 
for S. epidermidis and other samples yielding concordant, but less than 100% essential agreement, 
excess blood background in the output may contribute to the turbidity of the sample in AST panels. 
Since Phoenix AST continuously monitors panel wells for changes in turbidity, a sample with 
increased turbidity from blood background may not be detected as having any change in turbidity 
despite growth, thus decreasing the MIC and yielding inaccurate AST results. This potential 
explanation becomes apparent with lower concordance levels of lytic PBCs, which generally yield 
discolored outputs. A lower than actual MIC becomes especially problematic in the field when a 
sample may be called susceptible at a lower than actual concentration of drug, leading to 
ineffective killing of the bacteria. While this warrants further investigation on how to improve 
AST results, our baseline results were concordant with the reference method, again with the 
exception of S. epidermidis.   
Accuracy of MALDI Identification 
 Throughout all of our testing, MALDI proved to be the most difficult and inconsistent 
aspect. Poor accuracy from Lytic Anaerobic, Staphylococci, and other Gram positive PBCs 
implicate that both residual blood background and lack of bacteria impede accurate ID results. 
Even with adjustments to our processing workflow to account for these factors, difficulties with 
ID remained.  
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The ID results from increasing the filter pore size (Figure 16) showed that more CFU 
recovered and yielded a more accurate ID. Additionally, we found that outputs that yielded less 
than 108 total CFU consistently yielded a score classified as “no reliable ID;” however, several 
samples grown in Standard Aerobic (e.g. S. leggedness, E. faecium) and Lytic Anaerobic (e.g. E. 
coli, K. pneumoniae) media yielded 6x108 total CFU and also scored “no reliable ID.” Thus, while 
we can postulate that an increase in bacteria increases the accuracy of ID, we must fully understand 
the behavior of samples with ample bacteria that yield no reliable ID.  
Lack of accurate ID in samples with both low and high recovery rates may arise from 
limitations of our MALDI sample preparation. Previous work demonstrates that identification of 
Gram positive bacteria improves with extraction of proteins from bacterial colonies prior to 
application to the target plate15, 16. Throughout the entirety of this project, we applied bacterial 
colonies or PBC outputs directly to the target plate before using formic acid to disrupt cell 
membranes to release proteins. This allowed for a fast, simple protocol; however, improper 
extraction of proteins leads to a lack of analytes and insufficient generation of peaks. Thus, while 
increasing the number of CFU in the outputs may inherently aid in generating a more accurate 
peak, a larger number of bacteria may not be a necessary input to MALDI if we perform a more 
thorough extraction from the sample. 
Inaccurate IDs may also stem from diminishment of target peaks due to excess blood 
background and contaminants. Throughout the entirety of the baseline study, we saw that samples 
with visible amounts of blood background yielded poor MALDI results, if any at all. If residual 
blood proteins or even excess salts from saline washes remain at levels similar to that of the 
recovered bacteria, the contaminant peaks interfere with definition and identification of the target 
peaks. However, increasing the TEM pore size increases passage of both bacteria and RBCs, but 
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the additional blood background did not seem to hinder MALDI accuracy. Thus, the effect of blood 
background contamination must be further investigated. 
Flux Across the TEM and Cake Layer Formation 
 Based upon a decrease in flux across the TEM over time, we hypothesize that cake layer 
formation occurs. This becomes more apparent at smaller pore sizes, which corresponds to ease of 
clogging. Since this portion of the study aimed to identify potential causes of poor filtration for 
Gram positive bacteria, we only characterized the flux of Gram positive strains. While Gram 
negative bacteria generally perform well with no alterations in filtration, we still must characterize 
the flux across the TEM for these strains in order to get the complete picture of what occurs at the 
membrane.  
 A decrease in flux and subsequently low bacterial recovery implies hindrance at the TEM, 
but may be due to a lack of available sample in the filtrate rather than cake layer buildup. In order 
to prove cake layer buildup, a scanning-electron micrograph of the actual filter must be taken to 
observe microscale cake formation and clogging of pores. Meanwhile, collection and plating of 
the permeate from several consecutive time points will allow observation of the actual change in 
number of bacteria collected over time. In addition to aiding characterization of filtration, 
measuring the concentration of bacteria in permeate over time may allow for significant decrease 
in processing time. If all bacteria get collected after one minute and no additional bacteria filters 
after that point, filtration time can be reduced from approximately three minutes. 
Effect of Increasing Pore Size 
 In a first attempt to improve flux and bacterial recovery, we increased the pore size. With 
this, we saw increased percent recovery of Gram positive strains, most likely due to their ability 
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to fit through the pores despite clumping. We did not see any significant improvement for Gram 
negative strains, but more importantly we did not observe a decrease in ID/AST accuracy for those 
strains. This was originally a concern as we were uncertain if an increase in RBC passage would 
negatively impact downstream testing. While results proved that increasing the pore size improves 
the percent recovery and ID/AST results for Gram positive bacteria, we tested a limited sample 
size. In order to get more definitive answers and to implement this larger pore size into the PBC 
processing workflow, the study must be expanded across Standard Aerobic and Lytic Anaerobic 
media.  
 Based upon the RBC passage through a larger pore size and subsequent capability of the 
output to yield accurate ID/AST results, it becomes apparent that the need for more bacteria 
outweighs the interference of blood background. A large amount of outputs from the larger pore 
size contained discoloration similar to the outputs of lytic media, indicating excess blood 
background. While we originally hypothesized that this would interfere mostly with MALDI ID 
results, it was not the case and we yielded more accurate IDs. With this, we must further define 
the maximum pore size or, more generally, the optimal ratio of bacterial to RBC passage that 
allows for accurate ID/AST.  
CONCLUSIONS AND RECOMMENDATIONS 
PBC processing allows for separation of bacteria from blood cultures, yielding an input for 
accurate ID/AST results and ultimately decreasing the time to confirmatory bloodstream infection 
diagnosis by 18 hours. Preliminary baseline testing demonstrates that the technology is capable of 
processing blood cultures containing a wide variety of bacteria grown in various media types. 
While there remain necessary adjustments depending on the media and microorganism type, these 
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are relatively simple and easily applicable to an automated technology. This being said, the 
technology requires further development in order to fully optimize processing, especially for 
problematic Staphylococci strains. Moreover, understanding the limits of detection of the output 
in both MALDI ID and Phoenix AST is key to defining performance parameters for this 
development. 
There are several ways to improve processing performance and better prepare the final 
output for downstream testing. In order to minimize cake layer formation and maximize bacterial 
recovery, the physical geometry of the filter must be optimized. Simply increasing the size of the 
filter would create more surface area for sample flow and thus minimize pore clogging and cake 
filtration; however, the dimensions must remain feasibly in relation to the final disposable design. 
Alternatively, increasing the channel height would also increase the area through which the sample 
flows and thus decrease cake buildup. Once the geometry is optimized, both the flowrate of the 
peristaltic pump and pressure of the vacuum pump must be optimized in order to further maximize 
bacterial recovery. 
After alteration of the actual filter, it is important to conduct another baseline study and 
compare the results to those aforementioned. This will allow confirmation of optimization and 
determine if bacterial recovery is improved. Definition for the necessary amount of output for 
MALDI ID and Phoenix AST would aid in qualification of the new baseline results. Furthermore, 
analyzing MALDI itself in order to determine its tolerance of blood background would allow for 
an increase in the TEM pore size. With complete optimization of the physical filtration system and 
further definition of requirements for ID/AST, PBC processing can be implemented into an 
automated device. This will significantly improve the diagnosis of bloodstream infections and 










Chapter 2: Characterization of Fluorescence-Based 
Oxygen Depletion Sensor Formulations for Conversion 





The diagnostic workflow for a bloodstream infection begins with a blood draw into a 
culture bottle, which must then be transported to a lab for incubation in an automated instrument 
that monitors bacterial growth. Blood culture systems utilized glass collection bottles when they 
came on the market prior to the year 2000. However, transporting glass bottles creates safety 
hazards and high disposal costs, and over time there has been a trend toward centralized diagnostic 
labs that require inter-facility transport of incubated bottles. Conversion of blood culture bottles to 
a lightweight plastic allows for easier transportation, more economical disposal, and eliminates the 
hazards of broken glass and spills. This being said, adhesion of the fluorescence-based sensors 
necessary for detection of microorganism growth in a blood culture bottle remains poor as the 
sensors detach from the plastic bottle base. This detachment prevents detection of growth since 
blood culture components get between the sensor’s fluorescence indicator and the instrument’s 
photodetector, interfering with growth monitoring. Previous development efforts selected a 
promising adhesion promoter for proper stabilization of the sensor within BD’s plastic blood 
culture bottle; however, full characterization of the adhesion levels and signal ranges of new sensor 
formulations remain unclear.  
In order to define adhesion levels of two finalized sensor formulations—Sensor A and 
Sensor B—we developed a quantitative scale to minimize subjectivity of the previously 
established qualitative adhesion assay. This allowed us to select plasma treatment conditions for 
preparation of the polycarbonate bottles at the research and development site. From this, we 
prepared a pilot-scale evaluation of the adhesion level and dynamic range of Sensor A versus 
Sensor B using bottles plasma treated at the research and development site, as well as bottles 
plasma treated at the manufacturing site. Only Sensor A in polycarbonate bottles plasma treated at 
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the manufacturing site yielded adhesion similar the current product for sale; however, we found a 
higher baseline signal reading and thus narrower dynamic range for Sensor A. We selected only 
Sensor A to move forward with the scale-up process due to failure of Sensor B to adhere to the 
bottle. Biological testing of Sensor A will determine the effects of a smaller dynamic range on 
sensitivity of growth detection. Further development of alternate formulations is recommended 
should Sensor A yield performance issues during scale up. With this, full conversion of blood 
culture bottles to polycarbonate bottles will improve safety and ease of disposal, ultimately 





 While conversion of blood collection tubes from glass to plastic has been available for over 
ten years, plastic blood culture bottles for major automated systems only recently became available. 
Furthermore, many laboratories were slow to convert to plastic collection tubes due to various 
barriers18. With an increasing incidence of sepsis and larger quantities of blood cultures being 
processed, nurses and laboratory workers are increasingly at risk for exposure to blood borne 
pathogens. Specifically, the use of pneumatic tube systems that shuttle specimen vessels from 
collection points to labs can cause glass bottles to break and leak contaminated material. 
Conversion to plastic, shatterproof culture bottles not only eliminates this risk, but it produces 
significantly less medical waste as plastic bottles are smaller and weigh less than glass.  
 While conversion to plastic culture bottles improves safety and decreases disposal costs, 
the performance of the bottle’s sensor must be kept in mind. Glass inherently has a high surface 
energy, and thus the fluorescence-based sensors remain attached to the surface; however, 
polycarbonate plastic bottles possess a relatively low surface energy and thus their sensors require 
an inert adhesion promoter. Beginning in July 2016, BD began conversion to plastic for blood 
culture bottles containing fluorescence-based sensors that detect microorganism growth via carbon 
dioxide production19-21. While the adhesion promoter in these bottles successfully holds the sensor 
in place, conversion of culture bottles that detect oxygen depletion (i.e. culture bottles for detection 
of mycobacteria and fungi) yielded displacement of the sensor from the bottle with the suggested 
adhesion promoter. If this displacement occurs during incubation of the culture, growth detection 




 This project aimed to characterize the adhesion strength of two different formulations for 
the oxygen depletion sensor, as well as determine the sensor formulations’ effects on detection 
signal range. We first developed a scale in order to quantify adhesion and make comparison of the 
formulations more straightforward. We then compared the adhesion and signal levels of the two 
formulations to the current glass product for sale in order to select a formulation for biological 
verification testing and eventual scale up for manufacturing. 
BACKGROUND 
 The workflow of an automated blood culture system remains relatively straightforward, 
beginning with a blood draw into the culture bottle, transport to an automated culture instrument 
(e.g. BACTEC) for incubation, and then removal from the instrument after detection. Yet despite 
the workflow’s simplicity, pre- and post-incubation steps often require transport and disposal of 
large numbers of blood culture bottles to and from the laboratory. With heavy loads of glass bottles 
filled with often contaminated blood, it creates large potential for glass breakage, leakage of blood 
borne pathogens, and ultimately the delay of blood stream infection diagnosis. This warrants 
conversion of blood culture bottles from glass to a lighter material like polycarbonate, improving 
the workflow for operators and creating a safer environment for hospitals and labs. Differences in 
the surface chemistry of glass and plastics necessitates investigation of the bottles’ growth 
detection sensors in order to ensure proper performance with this conversion.  
Signal Detection with BACTEC Automated Blood Culture Systems 
 The BACTEC system exploits fluorescence to detect the growth of bacteria in a blood 
culture. All BACTEC blood culture bottles contain a fluorescence-based, disk-shaped silicone 
sensor at the base of the bottle. Each sensor contains a fluorescence indicator that reacts with the 
metabolites of growing bacteria to detect either an increase in carbon dioxide or a decrease in 
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oxygen. Light emitting diodes (LED) excite the indicator, which then emits fluorescence 
proportional to the amount of metabolite present in the culture22. Photo detectors in the BACTEC 
instrument continuously measure emission levels that are interpreted by pre-existing kinetic 
algorithms. These algorithms analyze emission levels and generate proportional voltage signals, 
which are used to flag a culture as positive based upon the rate of change in signal. 
For the purpose of this project, we focused on sensors that detect oxygen depletion. This 
sensor, in combination with the blood culture bottle medium, is critical for the detection of slow 
growing microorganisms such as mycobacteria and fungi. Two components of the sensor 
formulation—Component 1 and Component 2—are essential for detection. Component 1 is a 
pigment molecule that remains embedded in the main polymer network of the sensor, while 
Component 2 serves as the fluorescence indicator and remains flush against the base of the bottle. 
In order to maximize sensitivity of detection, Component 1 reflects excitation light from the LED 
back onto Component 2 and emission light from Component 2 towards the photodetector. The 
presence of oxygen quenches emission from Component 2, and thus a low fluorescence output 
from the sensor is initially detected23. As microorganisms grow they consume the oxygen present 
in the bottle, yielding an increase in signal as oxygen depletion occurs.  
In order to assess the sensor’s ability to detect oxygen or carbon dioxide changes, the 
dynamic range of the computer-generated voltage signal is calculated using the following equation: 
Dynamic Range= (Maximum Voltage)-(Baseline Voltage)
Baseline Voltage
×100%     [Equation 1] 
Since the target microorganisms of the oxygen depletion sensor may not grow to detection level 
for up to six weeks, a large dynamic signal range is necessary to ensure precise growth detection 
and avoid false positivity.  
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Sensor Formulation Components 
 Although the detailed chemistry of the sensor remains proprietary and beyond the scope of 
this project, knowledge of the main components is important for understanding changes in 
adhesion and dynamic range across formulations. Each formulation is comprised of three main 
structural components: (1) a silicone base polymer, which makes up a majority of the formulation; 
(2) a cross-linker to create the polymeric network of the sensor; and (3) an adhesion promoter that 
bonds to both the polycarbonate and the base polymer in order to adhere the sensor to the bottle. 
As previously mentioned, the sensors also contain two components necessary for growth detection. 
When all components are mixed together the materials remain in a viscous yet relatively thick 
liquid state. Preparation of bottles requires a five-hour minimum settling time immediately after 
dispensing the formulations into the bottle. This allows the fluorescence indicator (Component 2) 
to settle to the base of the bottle in order to maximize fluorescence detection. 
Once the components settle, they must be polymerized. With application of heat, three 
main reactions occur: (1) cross-linking of the base polymer; (2) linking of the adhesion promoter 
to the polycarbonate bottle; and (3) linking of the adhesion promoter to the base polymer network. 
Component 1 also becomes embedded in the main polymeric network while Component 2 remains 
flush against the bottom of the bottle, yielding two distinct layers within the sensor. This process 
occurs in an oven and results in a rubbery, disk-shaped sensor that ideally stays put at the bottom 
of the bottle. 
Plasma Treatment for Improved Adhesion 
 While polycarbonate is an ideal material for blood culture bottles due to its strength and 
lightweight nature, adhesion to its surface becomes difficult due to its relatively low surface energy 
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and potential contaminants (e.g. oils, dirt, etc.). Plasma treatment serves to improve adhesion by 
eliminating contaminants and increasing the surface oxygen content in order to promote chemical 
bonding24. In order to treat surfaces with plasma, the materials are placed in a chamber, which is 
evacuated to create a vacuum25. Air or another gas then flows into the chamber at low pressure 
before applying a high voltage across it to promote ionization and creation of free radicals on the 
surface of the polycarbonate. These free radicals react with the oxygen in the plasma to increase 
the surface energy of the polycarbonate by forming functional groups such as carboxyl, hydroxyl, 
and carbonyl groups26. At high enough power and/or long enough treatment times, plasma 
treatment also has the ability to etch the surface of the material being treated, improving adhesion 
through physical alteration. 
Previous Work for Conversion of Culture Bottles from Glass to Plastic 
 BD previously conducted several experiments in order to incorporate an adhesion promoter 
into the current glass oxygen depletion sensor formulation for conversion from glass to plastic 
blood culture bottles. Based upon recommendations from chemistry experts, one adhesion 
promoter was tested. After varying the ratios of adhesion promoter and other sensor components, 
two formulations—Sensor A and Sensor B—were selected based upon adhesion and signal 
performances. A plasma treatment study was also conducted in order to determine the optimal 
plasma treatment conditions for manufacturing. This yielded optimal manufacturing conditions of 
150W applied for 20 seconds.  
Detailed characterization of the adhesion and signal levels for both Sensor A and Sensor B 
remained unknown. Thus, determination of the adhesion levels and dynamic ranges of signal for 
each formulation is necessary before scaling up for verification of growth detection performance, 




The adhesion promoter of a sensor is critical for its stabilization within the culture bottle. 
It ensures that growth detection will not be affected by displacement of the sensor. Higher levels 
of adhesion promoter should theoretically yield stronger attachment; however, it is important to 
characterize any effects of increased adhesion promoter on the dynamic range of the sensor’s 
fluorescence signal and sensitivity to growth detection. Furthermore, an economical decision must 
be made in order to maintain efficient manufacturing. We first developed a quantitative scale to 
measure the level of adhesion of a sensor to a polycarbonate bottle. We then performed a 
preliminary adhesion study on Sensor A versus Sensor B to confirm the feasibility of both 
formulations. From this, we prepared a pilot scale batch to compare the adhesion and signal levels 
of Sensor A versus Sensor B in polycarbonate bottles treated at the research & development site 
versus at the manufacturing site. This allowed us to select optimal conditions for scale-up 
biological testing, which will ultimately determine which formulation goes to market. 
Overview of Workflow 
 For each step of this project, we followed the same workflow for sample preparation and 
downstream testing (Figure 17). 
 
Figure 17: Workflow for Sample Preparation and Downstream Performance Testing. Preparation of samples 
began with mixture of sensor formulations, which are viscous and mixed both by hand and by an electric mixer. Empty 
polycarbonate bottles were plasma treated and the sensor formulations were dispensed into the bottles. After 
dispensing, the bottles were held for five hours to allow the fluorescent dye to settle to the bottom of the bottles before 
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curing in an oven. A dry adhesion test was performed on cured bottles. 20mL of DI water were added to the remaining 
bottles, which were capped and autoclaved. Post-autoclave adhesion and dynamic range tests were performed on the 
autoclaved bottles. 
Sensor Formulations 
 We used previously developed sensor formulations throughout the entirety of this project. 
Our two formulations, A and B, differed only in the amount of adhesion promoter, with Sensor A 
containing twice the amount of adhesion promoter as Sensor B. After weighing the sensor 
materials, we mixed each formulation using an IKA Eurostar 60 digital mixer and dispensed 3mL 
of the specified formulation into plasma-treated polycarbonate bottles. 
Curing Program for Sensors 
 We used an oven to apply heat to the sensor formulations, initiating polymerization and 
adhesion of the sensors to the polycarbonate bottles. Herein, we refer to this process as curing. We 
used the same curing program for every sensor tested. The program took five hours in total and 
included an increase in temperature from room temperature to 100°C over one hour, followed by 
a four hour hold at 100°C before decreasing back down to room temperature.  
Dynamic Range Testing 
 We used a BACTEC 9240 to collect signal readings from our samples. In order to calculate 
dynamic range, we first collected baseline readings by placing autoclaved, decanted, and uncapped 
bottles in the BACTEC instrument and allowing the signal to stabilize. After five hours, we 
removed and capped the bottles before purging each bottle with nitrogen gas for one minute. This 
purge essentially quenched the fluorescence sensor and the subsequent reading served as the upper 
threshold of the sensor signal. In order to collect this reading, we reloaded the bottles into the 
BACTEC instrument, paying careful attention to place them in the same rack position at the same 
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orientation. We allowed the sensors to stabilize again for five hours. We calculated dynamic range 
using the baseline and nitrogen purge readings (see Appendix 2 for sample calculation). 
Scrape Test for Adhesion 
 In order to measure adhesion levels of the sensor to the polycarbonate bottle, we used a 
flathead screwdriver to scrape the sensor from the surface of the bottle. Proper adhesion can be 
visualized by a leftover residue on the bottom of the bottle, even after scraping away a majority of 
the sensor. We continued scraping the sensor until most of it came off of the bottle so that we could 
get an accurate depiction of where the sensor bonded to the bottle, if at all.  
We tested adhesion levels both before and after autoclave. The pre-autoclave scrape test 
allowed us to set a baseline for adhesion. Post-autoclave testing allowed us to determine the effects 
of autoclaving on adhesion levels, and, most importantly, qualify the final adhesion of the sensor 
since the final products are autoclaved. While this method allowed us to visualize whether or not 
the sensor adhered to the bottle, it remained a very qualitative method of assessment and warranted 
a more quantitative approach for assessment. 
Quantification of Adhesion Effectiveness 
 We prepared 16 replicates for eight different sensor formulations, referred to as conditions. 
We dispensed formulations into polycarbonate bottles plasma treated for 180 seconds and cured 
the bottles as per the general protocol. For both pre- and post-autoclave scrape tests, we used the 






Table 4: Quantitative Scale of Adhesion Level. 
Level of Adhesion Description Example* 
9 
Comparable to the current 
polycarbonate bottle containing 
the CO2 sensor, which is known 
as the “gold standard”; 
relatively difficult to scrape off; 
leftover residue is thick and 
patchy, and covers entire 




Substantial amount of residue is 
visible, but not as much or as 
difficult to scrape as a level 9; 
residue present on both bottom 




Minimal bonding to only one 
part of the bottle; residue only 
on sides of the bottle where the 
sensor attaches, or a small 
amount on the bottom of the 





No bonding; sensor comes off 
clean with no residue on the 
bottom or sides 
 
*Note: Pictures of examples are scrape test results of experiments unrelated to this project. Variations of sensor and 
residue color stems from the components of the particular condition, and are unrelated to adhesion. 
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Definition of Acceptable Plasma Treatment Level 
We plasma treated polycarbonate bottles at increasing lengths of time. For each length of 
time, we dispensed 3mL of Sensor A into the specified number of bottles, and 3mL of Sensor B 
into the specified number of bottles (Table 5). 
Table 5: Bottle Conditions for Assessment of Plasma Treatment Levels. 









We tested adhesion levels for each condition both before and after autoclave. This allowed us to 
confirm feasibility of each formulation, as well as determine the necessary length of plasma 
treatment at the R&D site moving forward for scale-up. 
Pilot Scale Evaluation 
 In order to confirm previous findings on a larger scale and perform preliminary testing 
before scale-up, we compared adhesion levels and dynamic ranges of four different conditions 
(Table 6). 
Table 6: Bottle Conditions for Pilot Scale Adhesion and Dynamic Range Assessment. 
Formulation Plasma Treatment Location and Parameters Replicates 
Sensor A  
Cayey, Puerto Rico  
20s at 150W 35 
Sparks, MD 
60s at 500W 35 
Sensor B 
Cayey, Puerto Rico 
20s at 150W 35 
Sparks, MD 




After curing, we scrape tested 10 bottles from each condition in order to quantify initial adhesion 
levels. After autoclaving the remaining bottles, we scrape tested another 10 from each condition 
in order to quantify the final adhesion level. We then performed dynamic range on the remaining 
15 bottles from each condition. 
RESULTS 
 Due to the subjective nature of the scrape test, we faced difficulties quantifying sensor 
adhesion as one of four levels. Thus, we developed a more robust method for calling adhesion 
acceptable or unacceptable. From this, we defined a feasible length of plasma treatment time for 
bottles prepared at the R&D site in Sparks, MD. While longer plasma treatment yielded better 
adhesion for both sensors, the feasible treatment time for manufacturing limited our selection to a 
treatment time for which only Sensor A yielded acceptable adhesion. From pilot scale testing, we 
further found that only Sensor A in bottles plasma treated at the manufacturing site yielded 
acceptable adhesion. This being said, we found that the increase of adhesion promoter in Sensor 
A narrows the dynamic range of voltage signal. Despite the smaller dynamic range compared to 
both Sensor B and the current glass product for sale, we selected only Sensor A to move forward 
in the scale-up process and toward production. 
Quantification of Adhesion Effectiveness 
 For this experiment, we aimed to assess the robustness of the four-level adhesion 
quantification scale. We were concerned with the ease of assigning an adhesion level rather than 
the actual adhesion levels of each condition, and thus will not go into detail about the physical 
description of the adhesion. We assigned adhesion levels to each of the eight replicates within each 
condition both pre- and post-autoclave. Across all eight conditions pre-autoclave, half of the 
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samples yielded a score of 6 while the other half yielded a score of 9 (Figure 19 A). Post-autoclave, 
51 samples yielded a score of 6 while the remaining 13 samples yielded a 9 (Figure 19 B). 
 
Figure 19: Distribution of Adhesion Levels. We assigned each replicate a level of adhesion both pre-
autoclave (A) and post-autoclave (B). 
60 
	
 While we assigned an adhesion level to each sample, this assignment remained very 
subjective. The results from this experiment yielded what we considered acceptable adhesion 
across all conditions and replicates, making it difficult to decipher between a “6” and a “9” despite 
the descriptions we developed for each level. This meant that placing the intermediate samples 
into one level or the other was based largely upon personal experience with the scrape test. This 
being said, we developed a binary quantification scale in order to avoid further subjectivity as 
much as possible and make selecting quality samples easier. This binary scale quantifies a sample 
as 0 or 1, with 0 yielding low or no adhesion and 1 yielding full or partial, thick residue. In other 
words, we moved towards a scale that qualified a formulation as passing (1) or failing (0) the 
scrape test. 
 From the original adhesion level scale, we found (with one exception) no bottle to bottle 
variability across one condition. For the pre-autoclave scrape test, all samples within the same 
condition yielded the same level of adhesion (Figure 20 A). For post-autoclave, we yielded the 
same consistency with the exception of condition 4, which yielded 5 samples at an adhesion level 





Figure 20: Bottle Adhesion Variability. We assessed the variability of adhesion across replicates 
within the same condition. We tested adhesion pre-autoclave (A) and post-autoclave (B). We tested eight 
replicates for each of the eight conditions. Each blue dot represents one replicate. The red box in (B) 







































The relative inconsistency of the post-autoclave condition 4 adhesion can be attributed to the 
subjectivity of the scrape test. As previously mentioned, the difference between calling adhesion 
level 9 versus level 6 often proved very difficult if samples laid between the two define descriptions. 
This being said, this experiment allowed us to confirm low to no sample variability across a 
condition. 
Definition of Necessary Level of Plasma Treatment 
 We scrape tested a portion of Sensor A and Sensor B samples both pre- and post-autoclave. 
We are always more concerned with the post-autoclave results and generally used the pre-
autoclave results in order to further understand what may cause failure of adherence. Sensor A 
dispensed into bottles plasma treated for 60 seconds passed the adhesion test pre-autoclave (Figure 
21, top), but autoclave noticeably decreased the adhesion (Figure 22, top). Still, we observed slight 
residue from this condition. Sensor B on the other hand yielded adhesion only on the sides of 60 
second-treated bottles with the remaining portion detaching cleanly from the bottle, thus failing 
the adhesion test. At 90 seconds of plasma treatment, Sensor A again experienced diminished 
adhesion post autoclave, but still yielded acceptable adhesion. Sensor B again detached cleanly, 




Figure 21: Pre-Autoclave Scrape Tested Bottle Bases of Sensor A versus Sensor B at Varying Plasma Treatment 
Times. We prepared bottles plasma treated at 60, 90, and 180 seconds and dispensed Sensor A or Sensor B into each. 
We scrape tested replicates of Sensor A bottles (left of all pictures) and Sensor B bottles (right of all pictures) for 
bottles plasma treated for 60 seconds (top), 90 seconds (middle), and 180 seconds (bottom). 
 
Figure 22: Post-Autoclave Scrape Tested Bottle Bases of Sensor A versus Sensor B at Varying Plasma 
Treatment Times. We prepared bottles plasma treated at 60, 90, and 180 seconds and dispensed Sensor A or Sensor 
B into each. After autoclaving the remaining un-scraped bottles, we scrape tested replicates of Sensor A bottles (left 
of all pictures) and Sensor B bottles (right of all pictures) for bottles plasma treated for 60 seconds (top), 90 seconds 
(middle), and 180 seconds (bottom). 
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Sensor B only yielded any sign of adhesion post-autoclave when treated for 180 seconds. This 
being said, 180 seconds of plasma treatment time is unfeasible for manufacturing. Even 90 seconds 
remains slightly too long for manufacturing, and thus we moved forward with a 60 seconds plasma 
treatment time. 
Pilot Scale Evaluation 
 We assessed the adhesion levels of all four bottle conditions both pre- and post-autoclave. 
We found that only Sensor A dispensed into bottles plasma treated in Cayey yielded adhesion on 
the level of the current sensor in the glass bottle post autoclave (Figure 23). All other conditions 
failed. 
 
Figure 23: Scrape-Tested Bottle Bases from Post-Autoclave Pilot Samples. We scrape tested samples from each 
condition and compared the results to the current glass sensor (left). Sensor A in bottles plasma treated in Cayey, 
Puerto Rico (top right) passed the scrape test while Sensor B in bottles plasma treated in Cayey (bottom right) and 




These results show not only that Sensor B does not adhere post-autoclave under any condition, but 
that the plasma treatments done in Sparks versus in Cayey yield different adhesion results. 
 We calculated the dynamic range of each bottle from the room air and nitrogen readings 
collected by the BACTEC 9240 (Figure 24). Sensor A plasma treated in Sparks and Cayey yielded 
averages of 200% and 204%, respectively. Sensor B yielded dynamic range averages of 296% and 
310% for bottles treated in Sparks and Cayey, respectively. The current glass sensor, which we 
used as a control, yielded an average dynamic range of 340%. 
 
Figure 24: Boxplot of Dynamic Range of Voltage Signal for Each Condition of Pilot Scale Testing. We plotted 
the distribution of dynamic ranges across samples for each pilot scale condition. We used the current glass product 
for sale as a control These control bottles were prepared in Cayey, Puerto Rico and shipped to Sparks, MD where 
we performed dynamic range testing. For each distribution, outliers are noted by an asterisk (*).  
Based upon these results, plasma treatment yields no significant effect on the dynamic range; 




















determine the cause for a smaller dynamic range, we looked specifically at the baseline and 
nitrogen readings of each sensor (Figure 25). 
 
Figure 25: Boxplots of Room Air and Nitrogen Voltage Readings for Each Sensor of Pilot Scale 
Testing. Dynamic range results showed that variation in plasma treatment does not significantly affect 
the dynamic range across the same sensor. Thus, we plotted the distributions of room air readings (top) 
and nitrogen readings (bottom) across all Sensor A, Sensor B, and glass sensor samples. Outliers are 
denoted by an asterisk. 
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From these results, we saw that more adhesion promoter increases the baseline voltage reading of 
the sensor while leaving the nitrogen reading relatively unaffected. This indicates potential 
interference of the adhesion promoter with oxygen detection. Moreover, the higher baseline 
reading and narrower dynamic range of both warrant assessment of the effects on the sensitivity 
of growth detection by the sensor. 
DISCUSSION 
 Conversion of the scrape test scale to one that calls a sensor as having acceptable or 
unacceptable adhesion allowed us to more clearly define parameters for sample preparation and 
select a formulation for further testing. Even with this, the scrape test remains inherently subjective, 
necessitating further investigation of methods to quantify and qualify sensor adhesion. While we 
did successfully select a sensor formulation and plasma treatment condition acceptable for scale-
up, this formulation yielded a narrower dynamic range than the current glass product for sale. 
Furthermore, the results of the scrape test necessitated that we move forward only with Sensor A 
in bottles plasma treated in Cayey since the remaining conditions yielded unacceptable adhesion. 
Although further testing and scale-up will determine whether or not the narrower dynamic range 
affects sensor performance, results of the pilot testing warrant investigation of the cause of a higher 
baseline voltage reading and potential solutions for lowering it to yield a dynamic range on the 
order of the glass product. 
Quantification of Adhesion 
 The scrape test is a highly qualitative, subjective method for assessing adhesion of a sensor 
to the BACTEC bottle. This made applying a quantitative scale to it very difficult, especially a 
scale with several levels. The difference between sensors that gave level 6 adhesion versus sensors 
that gave a level 9 adhesion proved minimal. Since both conditions yield adhesion throughout the 
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entire base of the bottle, both could be selected as a final product. Moreover, even a sensor yielding 
a level 3 adhesion could potentially be selected if it yields adhesion around the edges of the sensor, 
which would prevent culture material from seeping between the fluorescence indicator and 
detector. Defining adhesion levels on a binary scale allows for clearer definition of the 
formulations we should pursue for further testing by classifying them as acceptable or 
unacceptable. This eliminates any grey areas in placing sensors in one of four categories. 
 Calling a sample “acceptable” or “unacceptable” without a quantitative measurement 
remains subjective despite having references from current products. In order to accurately define 
adhesion levels that are acceptable and unacceptable, a quantitative measurement must be 
developed. From this, samples can be consistently tested for adhesion and confidently called as 
yielding acceptable or unacceptable adhesion. Due to the urgency and scope of this project, time 
did not permit development of a method; however, one suggestion for development includes 
defining a pull-up or scrape force limit that the sensor can tolerate before failing. Specifically, 
inverting the bottles and placing them in a swinging-bucket rotor centrifuge and increasing the 
speed until the sensor detached could serve as an accurate, efficient way to quantify the adhesion 
level of the sensor. While the swinging-bucket rotor may better simulate agitation of the blood 
culture bottle in a BACTEC, inverting the bottles in a fixed-angle rotor may serve better to define 
a force that the sensor can withstand. A method such as this would allow for more systematic 
development of all sensors of blood culture bottles. 
Plasma Treatment Levels and Variations 
 For bottles plasma treated at the R&D site, increasing the length of treatment time 
noticeably increases the adhesion level of the sensor. While Sensor A showed increasing levels of 
adhesion across all lengths of time tested, Sensor B just barely started showing signs of adhesion 
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at the longest treatment time, 180 seconds. Thus, despite a positive correlation between plasma 
treatment time and adhesion, increasing treatment cannot fully make up for a smaller amount of 
adhesion promoter. For experimental purposes, one could continue to increase the plasma 
treatment time in order to determine the length of treatment time that yields the same adhesion 
levels as increased adhesion promoter i.e. Sensor A; however, longer plasma treatment times only 
increase manufacturing time. From a manufacturing standpoint, even 90 seconds would slow high 
throughput production, and thus a compromise between more adhesion promoter versus more 
plasma treatment must be made. 
 While increasing the length of time and holding the power of plasma treatment constant 
improves adhesion, stronger and longer plasma treatments may not be necessary. The power and 
length of plasma treatment at the manufacturing site (150W for 20s) was significantly lower and 
shorter than the power and length that we applied to bottles prepared at the R&D site (500W for 
60s). The results of the pilot scale testing showed not only that Sensor A yields better adhesion 
than Sensor B, but that bottles plasma treated at the manufacturing site yield better adhesion than 
those treated at the R&D site. In terms of plasma treatment conditions, this suggests two possible 
explanations: (1) increasing the power of plasma treatment yields less favorable surface 
modification for adhesion; or (2) the equipment at the manufacturing site provides a more 
concentrated treatment, yielding increased surface modification and adhesion. While both 
explanations are possible, the second seems more likely based upon the conditions of the R&D 
plasma treatment instrument versus the manufacturing instrument. The plasma treatment 
instrument at the R&D site is a batch process. The instrument is very large and the samples take 
up less than 1/3 of the total volume inside the treatment chamber where the plasma is distributed 
more or less evenly throughout. The manufacturing site employs a continuous process, using an 
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assembly line apparatus that essentially applies the plasma treatment in a concentrated beam. This 
may provide a more even, direct surface modification for better adhesion.  
It is critical to investigate the differences between plasma treatments we employ for 
development and plasma treatments applied in manufacturing. Defining these differences and 
developing a conversion factor to create equal conditions between development and manufacturing 
will minimize differences and unexpected adhesion issues experienced during scale-up. Moreover, 
if developmental processing conditions do not mimic manufacturing conditions, it becomes 
difficult to develop feasible solutions. Thus, it is important not only that the effect of plasma 
treatment is better understood, but that we are able to simulate manufacturing conditions for small 
scale R&D testing. 
Pilot Scale Evaluation 
 Since proper sensor adhesion is required to avoid leakage of blood culture sample and 
interference with growth detection, the adhesion test essentially serves as a first line of assessment 
to eliminate any unacceptable formulations. As previously discussed, we found variation in 
adhesion for bottles treated at the manufacturing versus R&D sites. Thus, only Sensor A plasma 
treated in Cayey passed the adhesion test. We continued to characterize the signal ranges of every 
condition despite lack of feasibility of moving forward with Sensor B.  
 Quality testing on the current glass product does not include dynamic range testing. Thus, 
we included the glass bottle in all testing as a reference and found narrower dynamic range for all 
conditions. No significant variation in dynamic range across the same sensor with different plasma 
treatments indicates that surface modifications to the bottle have no effect on dynamic range; 
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however, adding and increasing the amount of adhesion promoter increased the baseline reading 
and effectively narrowed the dynamic range.  
The detailed chemical mechanisms of the sensor are beyond the scope of this project. This 
being said, a higher room air reading and constant nitrogen reading of a sensor that detects 
diminishing oxygen levels suggests that the adhesion promoter interferes with the detection of 
oxygen. Testing a formulation with a similar adhesion promoter with less functional groups than 
the current promoter in development may prevent this interference and increase the dynamic range. 
Yet while a smaller dynamic range may suggest a lower sensitivity to oxygen depletion and thus 
bacterial growth, further biological testing must be done in order to determine if it does in fact 
affect sensor performance. 
CONCLUSIONS AND RECOMMENDATIONS 
For conversion of fluorescence-based sensors from glass to polycarbonate bottles, 
increasing the amount of adhesion promoter in the formulation and applying short, concentrated 
plasma treatment to the bottles provides the sensor with even adhesion to the bottle base. In order 
to yield acceptable adhesion however, the detection signal readings become compromised as more 
adhesion promoter narrows the dynamic range. Unknowns relative to the amount of necessary 
sensor adhesion to prevent sensor displacement, as well as the effects of narrowed dynamic range 
on detection sensitivity, make it difficult to optimize conditions for conversion to plastic bottles. 
A quantitative measurement of sensor adhesion would allow for definition of standards for 
what qualifies a formulation as yielding acceptable versus unacceptable attachment. Generally 
speaking, quantifying the force necessary to detach the sensor from the bottle allows establishment 
of thresholds and characterization of formulation adhesion. Centrifuging inverted bottles or 
applying a force gauge to pull up the sensors are simple, cost-effective solutions for this 
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quantification. With a method and standards in place, determining the effects of differing levels of 
adhesion promoter and plasma treatment becomes easier and allows for more strategic 
development of formulations.  
 Once sensor attachment standards are established, alterations to formulations must focus 
on signal detection. We saw that increased adhesion promoter yielded a higher baseline signal and 
narrowed the dynamic range, but whether or not this will negatively impact detection sensitivity 
remains unknown. It is recommended not only that scaled up biological testing on the Sensor A 
formulation is performed, but also that further investigation occurs to determine why increased 
adhesion promoter increases the baseline reading. Additionally, formulation development using 
alternative adhesion promoters with less functional groups may improve sensor attachment without 
decreasing the dynamic range. With a better understanding of the attachment and dynamic range 
levels necessary for accurate growth detection, full conversion from glass to plastic bottles can be 
made. This will allow for easier transport and disposal of BACTEC blood culture bottles, 
ultimately decreasing the cost and time required for employing the diagnostic workflow for blood 
stream infections.  
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APPENDIX 1: ADDITIONAL FIGURES AND TABLES 
Table A1.1: Microorganisms Tested in Baseline Study. 
TYPE ID CHARACTERISTICS 
Gram Negative Acinetobacter baumannii wild type 





Gram Negative Enterobacter cloacae wild type 
Gram Negative Enterobacter cloacae high-level cAmpC 
Gram Negative Escherichia coli wild type 
Gram Negative Escherichia coli 
Original-spectrum β-
lactamase (ESBL)-producing 
Gram Negative Escherichia coli 
NDM, aminoglycoside 
resistant 
Gram Negative Klebsiella pneumoniae wild type 
Gram Negative Klebsiella pneumoniae 
extended-spectrum β-
lactamase (ESBL)-producing 




Gram Negative Pseudomonas aeruginosa wild type 
Gram Negative Pseudomonas aeruginosa MDR, VIM-2-producing 
Gram Negative Proteus mirabilis wild type 
Gram Negative Proteus mirabilis ESBL 
Gram Negative Serratia marcescens wild type 
Gram Negative Serratia marcescens SME-1-producing 
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Gram Positive Enterococcus faecalis 
Vancomycin resistant 
Enterococci (VRE) (vanB) 
Gram Positive Enterococcus faecalis wild type 
Gram Positive Enterococcus faecium wild type 
Gram Positive Enterococcus faecium VRE 
Gram Positive Staphylococcus aureus wild type, NCF pos 




Gram Positive Staphylococcus aureus wild type, NCF neg, pen S 
Gram Positive Staphylococcus aureus MRSA 
Gram Positive Staphylococcus epidermidis wild type 
Gram Positive Staphylococcus epidermidis Tetracycline resistant 
Gram Positive Staphylococcus lugdunensis 
Clindamycin and 
erythromycin resistant 
Gram Positive Staphylococcus saprophyticus 
Oxacillin and penicillin 
resistant 
Streptococcus Streptococcus pneumoniae resistant 






















Expected CFU/mL in 
Original Sample if Plate is 
Readable [multiplier] 
1 
210µL output tube or 
PBC into 20mL saline 
10-2   
2 































Figure A1.1: Total CFU in Original PBC versus Output for Each Microorganism and Media Type Tested in 
the Baseline Study. We averaged the PBC and output plate counts across the strains of each microorganism for 
each type of media, and then used these counts to calculate the percent recovery of bacteria from filtration. (A-B) 
Standard Aerobic Media. (C-D) Lytic Anaerobic Media. (Note: BACTEC detected no growth for A. baumanii and 





APPENDIX 2: SAMPLE CALCULATIONS 
Sample Calculation for Dynamic Range of Fluorescence-Based Oxygen Sensor 
 After performing the dynamic range protocol, the mean signal readings after stabilization 
at room air exposure and stabilization at zero-oxygen levels (nitrogen gas purge) can be collected 
for each bottle. The room air reading serves as the baseline signal level and accounts for any signal 
noise, while the nitrogen purge reading serves as the maximum signal level. The dynamic range is 
calculated by substituting these values into Equation 1 to yield: 
Dynamic Range= (Nitrogen Voltage)-(Room Air Voltage)
Nitrogen Voltage
×100%     [Equation 2]  
If the stabilized room air reading is measured as 0.268V and the stabilized nitrogen purge reading 
is measured as 1.135V, the dynamic range can be calculated as follows: 
Dynamic Range= 1.135-0.268
0.268
×100% = 324%         [Equation 3]  
This calculation was performed for each sensor, and the average dynamic range was then 
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